TMC Venture Fund is the venture capital arm of Texas Medical Center Corporation, investing in early-stage healthcare and life sciences companies. It focuses on digital health, medical devices, and therapeutics, partnering with entrepreneurs shaping the future of global health.
30% of their portfolio is in Healthcare. Their most common stage is series-a (40% of deals). Average disclosed round size is $15.6M (across 9 rounds with reported amounts).
Portfolio
9
Fund Size
$50M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Path EX, Inc. | Unknown | $5M | May 2025 |
 Nua Surgical | Series A | — | Dec 2024 |
| PPrana Thoracic | Series A | $3M | Aug 2024 |
 Crossbridge Bio | Seed | $10M | Jan 2024 |
| VVolnay | Series A | $28.4M | Jan 2024 |
| AAlleviant Medical, Inc. | Unknown | $75M | — |
| Path EX, Inc. | Unknown | $5M | — |
 CorInnova | Unknown | $20K | — |
 Medical Informatics Corp. | Series A | $11.9M | — |
| NNoninvasix | Seed | $2M | — |
Top Co-Investors
Alexandria Venture Investments2 shared
IAG Capital Partners2 shared
Fitz Gate Ventures2 shared
Crescent Enterprises1 shared
Portal Innovations1 shared
CE Ventures1 shared
4BIO Capital1 shared
Cancer Focus Fund1 shared
Mission BioCapital1 shared
ShangBay Capital1 shared
RiverVest Venture Partners1 shared
Gilmartin Capital1 shared
S3 Ventures1 shared
Vensana Capital1 shared
Keiretsu Forum1 shared
DCVC1 shared
Intel Capital1 shared
Philips Ventures1 shared
cultivate(MD)1 shared
Enterprise Ireland1 shared
Last updated: 20 October 2026